Delivery Order SPE2DB24D2205-SPE2DB25FEGPT
- Not listed
- The Defense Logistics Agency issued a delivery order for NEMLUVIO 30 mg pens valued at $3,858.40 to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award, made on August 25, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement. Performance will take place at...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens, with an ultimate completion date of August 22, 2025. This contract was competitively awarded without set-aside designation under firm fixed price terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens under contract 4569086102. This firm fixed price delivery order, issued on August 13, 2025, is part of a larger indefinite delivery contract (IDC) vehicle and represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a $3,858.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 4, 2025. This non-set-aside contract represents a competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery will be fulfilled at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Nemluvio 30 mg pens, with a completion date of September 10, 2025. This delivery order contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nemluvio 30 mg pens, a pharmaceutical product used in the treatment of certain medical conditions. This firm fixed-price delivery order is set to be completed by September 2, 2025, and will be fulfilled at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor, AmerisourceBergen was selected...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,929.20 firm fixed-price delivery order is for the supply of "NEMLUVIO 30 MG PENS" medical products. The contract has an ultimate completion date of April 25, 2025 and was awarded on April 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGPTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader federal contracting relationship with the agency. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a wide range of medications and medical commodities to support military healthcare systems, the Defense Health Agency, and other government healthcare customers. The contract award reflects the contractor's established capability to fulfill federal pharmaceutical requirements through open competition and its critical role in supporting military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/21/25 |